Category: Diabetes

Diabetes Observational Study

The Absolute Risk of Incident Type 2 Diabetes Following Exposure to Systemic Corticosteroids in Selected Steroid-related and Phenotypic Groups

Post author By Ambery P, Eryd S A, Jenkins-Jones S, Heywood B, Berni E R, Brown M, Astbury C, Hunt P and Currie C J
Post date 6 July 2022

Ambery P, Adamsson Eryd S, Jenkins-Jones S, Heywood B, Berni E, Brown M N, Astbury C, Hunt P, Currie C J. 6 Jul 2022

Diabetes Retrospective Study

Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study

Post author By Morgan C L, Qiao Q, Grandy S, Johnsson K, Jenkins-Jones S, Holden S E and Currie C J
Post date 9 January 2018

Morgan C L, Qiao Q, Grandy S, Johnsson K, Jenkins-Jones S, Holden S E & Currie C J. 09 Jan 2018

Diabetes

Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival

Post author By Currie C J, Holden S E, Jenkins-Jones S, Morgan C L, Voss B, Rajpathak S N, Alemayehu B, Peters J R and Engel S S
Post date 9 November 2017

Currie C J, Holden S E, Jenkins-Jones S, Morgan C L, Voss B, Rajpathak S N, Alemayehu B, Peters J R and Engel S S. 09 Nov 2017

Diabetes

Evaluation of the clinical effectiveness in routine practice of fluocinolone acetonide 190 µg intravitreal implant in people with diabetic macular edema

Post author By Holden S E, Currie C J and Owens D R
Post date 7 September 2017

Holden S E, Currie C J, Owens D R. 07 Sep 2017

Diabetes

Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: A retrospective database study

Post author By Holbrook T, Tang Y, Das R, Shankar R R, Tunceli K, Williams J, Radican L, Holden S E, Morgan C L, Piercy J and Currie C J
Post date 23 May 2017

Holbrook T, Tang Y, Das R, Shankar R R, Tunceli K, Williams J, Radican L, Holden S E, Morgan C L, Piercy J, Currie C J. 23 May 2017

Comparitive Effectiveness Diabetes

Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data

Bain S, Druyts E, Balijepalli C, Baxter C A, Currie C J, Das R, Donnelly R, Khunti K, Langerman H, Leigh P, Siliman G, Thorlund K, Toor K, Vora H J, Mills E J. 14 Nov 2016

Diabetes

Diabetes and Cancer

Post author By Holden S E
Post date 19 January 2016

Holden S E. 19 Jan 2016

Diabetes Diabetes Obesity & Metabolism

Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer

Post author By Holden S E, Jenkins-Jones S, Morgan C L, Schernthaner G and Currie C J
Post date 14 November 2014

Holden S E, Jenkins-Jones S, Morgan C L, Schernthaner G, Currie C J. 14 Nov 2014

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Copyright^© Human Data Sciences – All rights reserved

Site by Create Summit

Copyright © Human Data Sciences – All rights reserved